DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
October 27 2023 - 4:30PM
Montrouge, France, October 27, 2023
DBV Technologies to Report Third Quarter
2023 Financial Results and Business Update
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that the Company will
host a conference call and live audio webcast on Tuesday, October
31st, at 5:00 p.m. ET to review third quarter 2023 financial
results and provide a business update.
Interested participants may access this call via
the below teleconferencing numbers and asking to join the DBV
Technologies call:
- United States: 1-844-481-2866
- International: 1-412-317-1859
A live webcast of the call will be available on
the Investors & Media section of the Company’s website:
https://www.dbv-technologies.com/investor-relations/. A replay of
the presentation will also be available on DBV’s website after the
event.
About DBV TechnologiesDBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin is based on epicutaneous immunotherapy, or
EPIT™, and is DBV Technologies’ method of delivering biologically
active compounds to the immune system through intact skin. With
this new class of non-invasive product candidates, the Company is
dedicated to safely transforming the care of food allergic
patients. DBV Technologies’ food allergies programs include ongoing
clinical trials of Viaskin Peanut. DBV Technologies has global
headquarters in Montrouge, France, and North American operations in
Basking Ridge, NJ. The Company’s ordinary shares are traded on
segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345)
and the Company’s ADSs (each representing one-half of one ordinary
share) are traded on the Nasdaq Global Select Market (Ticker:
DBVT).
Investor Contact Katie
MatthewsDBV Technologies+1
857-529-2563katie.matthews@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393
angela.marcucci@dbv-technologies.com
Viaskin and EPIT are trademarks of DBV
Technologies.
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From Apr 2024 to May 2024
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From May 2023 to May 2024